Lawrence Richman
Neurology · Los Angeles, CANPI 1770709933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 9.2% — the pattern of someone who eats at a lot of different presentations.
Across 61 payments — averaging $24.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$135
- Amgen$133
- AbbVie$126
- Heartflow, Inc.$116
- Lilly USA, LLC$90
- Amarin Pharma, Inc.$73
- plus $799 from 23 others
What the payments were for
- Food & beverage$1,473100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 4 | $135 |
| Amgen | 6 | $133 |
| AbbVie | 5 | $126 |
| Heartflow, Inc. | 5 | $116 |
| Lilly USA, LLC | 4 | $90 |
| Amarin Pharma, Inc. | 4 | $73 |
| Johnson & Johnson | 3 | $66 |
| Alnylam Pharmaceuticals Inc. | 3 | $63 |
| Sanofi | 2 | $60 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $53 |
| Novo Nordisk | 2 | $51 |
| Boehringer Ingelheim | 2 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $48 |
| Pfizer | 2 | $45 |
| Avanos Medical | 1 | $37 |
| Lexicon Pharmaceuticals, Inc. | 1 | $35 |
| Sanofi Pasteur Inc. | 1 | $32 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Bayer | 1 | $24 |
| Eisai Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Nalpropion Pharmaceuticals LLC | 1 | $17 |
How this compares
$1,473 in reported general payments places this provider in the 55th percentile of 1,996 neurology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 12 | $978 |
| Tamsulosin Hcl | 11 | $27 |
| Amlodipine Besylate | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other neurology in Los Angeles
- Perry ShiehLos Angeles$2.4M
- David LiebeskindLos Angeles$1.9M
- John SternLos Angeles$999K
- Jeffrey CummingsLos Angeles$918K
- Alan RapoportLos Angeles$808K
- Alon AvidanLos Angeles$505K
- Mark LewLos Angeles$450K
- Dawn EliashivLos Angeles$364K
- Richard LewisLos Angeles$309K
- Margaret BurnettLos Angeles$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.